TABLE 4.

Pathology findings in the lung, by disease duration (early vs. late death).

	Early death (n = 10)	Late death (n = 10)	p value
Admission to the ICU	3 (30%)	5 (50%)	0.65
SARS-CoV-2 detected in the lung biopsy	6 (60%)	7 (70%)	1
Histopathological assessment of the lungs:	n = 10	n = 9
Diffuse/focal inflammatory lesions	1/9	7/2	0.01
Acute lesions	6 (60%)	6 (66.7%)	1
Subacute lesions	10 (100%)	8 (88.9%)	0.47
Fibrinous alveolitis	2 (20%)	3 (33.4%)	0.63
Macrophagic alveolitis	10 (100%)	9 (100%)	1
Neutrophilic alveolitis	4 (40%)	3 (33.4%)	1
Organizing pneumonia with fibrous buds in the alveoli	5 (50%)	7 (77.8%)	0.35
Collapsed alveoli	7 (70%)	6 (66.7%)	1
Dystrophic pneumocytes	6 (60%)	7 (77.8%)	0.63
Macrophages in interalveolar septa	7 (70%)	5 (55.6%)	0.65
Lymphocytes in interalveolar septa	10 (100%)	8 (88.9%)	0.47
Lymphocytic vasculitis	6 (60%)	2 (22.3%)	0.17
Thrombosis	5 (50%)	7 (77.8%)	0.35